Binding of Aggregated Immunoglobulins to the Human Platelet Fc Receptors: A Mechanism of Platelet to Platelet Bridging

Summary

Aggregated immunoglobulins react with human platelets by occupying the Fc receptors present on their surface, inducing aggregation and the release reaction. We studied the effect of heat aggregated gammaglobulins (HAGG) on ADP-induced aggregation of platelets. We used the minimum concentration of ADP required to induce a reversible aggregation of platelets without any substantial amount of serotonin (14C 5HT) release. EDTA (5 mM) added at the peak of platelet aggregation resulted in rapid deaggrcgation ot these platelets. However, incubation of platelets with HAGG at a dose that did not by itself induce any aggregation or release reaction, followed by ADP addition resulted in an irreversible platelet aggregation of greater magnitude accompanied by a substantial release of 14C-5HT. The addition of EDTA at the peak of platelet aggregation failed to deaggregate these platelets. To determine whether the augmented aggregation response and the inhibition of deaggiega-tion was due to HAGG or a consequence of platelet release products, we used thrombin-degranulated platelets. The augmented aggregation response and the inhibition of deaggregation due to HAGG and ADP could be demonstrated using these platelets. To confirm that the binding of HAGG to the platelet Pc receptors was responsible for these observations, we incubated platelets with an excess of Fc fragments of IgG prior to the addition of HAGG and ADP. This abolished the aggregation response observed previously. From this study we conclude that interplatelet bridging by HAGG renders the platelets hyperag-gregable and appears to be a mechanism involved in maintaining platelet aggregates.

Keywords

Platelet release reaction - Deaggregation - Immunoglobulins - Fc receptors

• References

• 1 Kunicki TJ, Pidard D, Rosa JP, Nurden AT. The formation of Ca₊₊-dependent complexes of platelet membrane-glycoproteins lib and Ilia in solution as determined by crossed immunoelectrophoresis. Blood 1981; 58: 268-278
• 2 Nachman RL, Leung L LK. Complex formation of platelet membrane glycoproteins lib and Ilia with fibrinogen. J Clin Invest 1982; 69: 263-278
• 3 Packham MA, Mustard JF. Normal and abnormal platelet activity. In: Blood Platelet Function and Medicinal Chemistry. Lasslo A. (Ed.), p 61-128 Elsevier Biomedical; New York, NY: 1984
• 4 Phillips DR, Jennings LK, Prasannn HR. Cn mediated association of glycoprotein G (thrombin-sensitive protein, thrombospondin) with human platelets. J Biol Chem 1980; 255: 11629-11632
• 5 Kinlough Rathbonc RL, Mustard JF, Terry DW, Dejana E, Cazenave J-P, Packham MA, Harfenist EJ. Factors influencing the. deaggregation of human and rabbit platelets. Thromb Haemostas 1983; 49: 162-167
• 6 Kinlough-Rathbonc RL, Mustard JF, Packham MA, Haifenisl EJ. Factors influencing the deaggregation of chymotrypsin-treated human platelets aggregated by fibrinogen. Thromb Haemostas 1983; 49: 196-198
• 7 Kinlough-Rathbone RL, Perry DW, Packham MA, Mustard JF. Deaggregation of human platelets aggregated by thrombin. Thromb Haemostas 1985; 53: 42-44
• 8 Robison GA, Arnold A, Hartmann RC. Divergent effects of epinephrine and prostaglandin E on the level of cyclic AMP in human blood platelets. Pharmacol Res Comm 1969; 1: 325-329
• 9 Henson PM, Ginsberg MH. Immunological reactions of platelets. In: Platelets in Biology and Pathology. Gordon JL. (Ed.), p 265 North-Holland Biomedical Press; New York, NY: 1981
• 10 Gocke DJ. In vitro damage of rabbit platelets by an unrelated antigen-antibody reaction. II. Studies of the plasma requirement. J Immunol 1965; 94: 247-252
• 11 Henson PM. Mechanisms of release of constituents from rabbit platelets by antigen-antibody complexes and complement. I. Lytic and non-lytic reaction. J Immunol 1970; 105: 476-489
• 12 Dixon R, Rosse W, Ebbert L. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. N Eng J Med 1975; 292: 230-236
• 13 Hymes K, Shulman S, Karpatkin S. A solid-phase radioimmunoassay for bound antiplatelet antibody. J Lab Clin Med 1979; 94: 639-648
• 14 Kelton JG, Giles AR, Neame PB, Powers P, Hageman N, Hursh J. Comparison of two direct assays for platelet associated IgG (PA IgG) in assessment of immune and nonimmune thrombocytopenia. Blood 1980; 55: 424-429
• 15 Nel JD, Stevens K. A new method for the simultaneous quantitation of platelet bound immunoglobulin (IgG) and complement (C3) employing an enzyme-linked immunoabsorbent assay (ELISA) procedure. Br J Haematol 1980; 44: 281-290
• 16 Mueller-Eckhardt C, Kayser W, Mersh-Baumert K, Mueller-Eckhardt G, Breidenbach M, Kugel HG, Graubner M. The clinical significance of platelet-associated IgG: A study of 298 patients with various disorders. Br J Haematol 1980; 46: 123-131
• 17 Movat HZ, Mustard JF, Taichman NS, Uriuhara T. Platelet aggregation and release of ADP, serotonin and histamine associated with phagocytosis of antigen-antibody complexes. Proc Soc Exp Biol USA 1965; 120: 232-237
• 18 Pfueller SL, Luscher EF. The effects of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities. I. Studies of immunoglobulins of different types. J Immunol 1972; 109: 517-524
• 19 Henson PM, Spiegelberg HL. Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and sublasses. J Clin Invest 1973; 52: 1282-1288
• 20 Clark WF, Tevaarwerk G JM, Reid BD. Human platelet-immune complex interaction in plasma. J Lab Clin Med 1982; 100: 917-931
• 21 Clark WF, Tevaarwerk G JM, Plomley RF, Reid BD, Parbtani A. Spontaneous aggregates of immunoglobulin-G prime the human platelet release reaction induced by close cell contact. Thrombos Res 1987; 47: 709-717
• 22 Mustard JF, Perry DW, Ardlic N, Packham MA. Preparation of suspensions of washed platelets from humans. Br J Haematol 1972; 22: 193-204
• 23 Harlemsl EJ, Guccione MA, Packham MA, Mustard JF. The, use nf the synthetic peptide Gly-Pro-Arg-Pro in the preparation of thrombin-degranulated rabbit platelets. Blood 1982; 59: 952-955
• 24 Laudano AP, Doolittle RF. Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerisation of fibrin monomers. Proc Natl Acad Sci USA 1978; 75: 3085-3089
• 25 Born G VR, Cross MJ. The aggregation of blood platelets. J Physiol 1963; 168: 178-195
• 26 Mustard JF, Packham MA, Kinlough-Rathbone RL, Perry DW, Regoeczi E. Fibrinogen and ADP-induced platelet aggregation. Blood 1978; 52: 453-466
• 27 Lawrie JS, Ross J, Kemp GD. Purification of fibrinogen and the separation of its degradation products in the presence of calcium ions. Biochem Soc Trans 1979; 7: 693-694
• 28 Israels E, Nish G, Paraskevas F, Israels LG. Platelet Fc receptor as a mechanism for Ag-Ab complex-induced platelet injury. Thromb Diath Haemorrh 1973; 29: 434-444
• 29 Cheng CM, Hawiger J. Affinity isolation and characterization of immunoglobulin G Fc fragment-binding glycoprotein from human blood platelets. J Biol Chem 1979; 254: 2165-2167
• 30 Kinlough-Rathbone RL, Packham MA, Mustard JF. Synergism between platelet aggregating agents: the role of arachidonate pathway. Thrombos Res 1977; 11: 567-580
• 31 Grant JA, Scrutton MC. Positive interaction between agonists in the aggregation of human blood platelets: interaction between ADP, adrenaline and vasopressin. Br J Haematol 1980; 44: 109-125
• 32 Clark WF, Tevaarwerk G JM, Reid BD, Hall S, Caveney A, Parbtani A, Kreeft J. Calcium and the Fc receptor on human platelets. Thromb Haemostas 1987; 57: 298-301